James Keaney

1.8k total citations · 1 hit paper
17 papers, 1.2k citations indexed

About

James Keaney is a scholar working on Neurology, Molecular Biology and Neurology. According to data from OpenAlex, James Keaney has authored 17 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Neurology, 6 papers in Molecular Biology and 6 papers in Neurology. Recurrent topics in James Keaney's work include Neuroinflammation and Neurodegeneration Mechanisms (5 papers), Endoplasmic Reticulum Stress and Disease (3 papers) and Barrier Structure and Function Studies (3 papers). James Keaney is often cited by papers focused on Neuroinflammation and Neurodegeneration Mechanisms (5 papers), Endoplasmic Reticulum Stress and Disease (3 papers) and Barrier Structure and Function Studies (3 papers). James Keaney collaborates with scholars based in Ireland, United States and Belgium. James Keaney's co-authors include Matthew Campbell, Marian M. Humphries, Irena Kadiu, Gaëlle Gillet, Peter Humphries, Anna‐Sophia Kiang, Diana Scholz, John J. Callanan, Colin P. Doherty and Eugene Wallace and has published in prestigious journals such as Nature, Nature Communications and Human Molecular Genetics.

In The Last Decade

James Keaney

17 papers receiving 1.2k citations

Hit Papers

The dynamic blood–brain barrier 2015 2026 2018 2022 2015 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James Keaney Ireland 9 494 475 254 191 104 17 1.2k
Sae‐Won Lee South Korea 18 709 1.4× 480 1.0× 92 0.4× 116 0.6× 174 1.7× 23 1.5k
Katrin Frauenknecht Germany 22 451 0.9× 260 0.5× 244 1.0× 140 0.7× 165 1.6× 57 1.2k
Allison M. Andrews United States 16 477 1.0× 320 0.7× 367 1.4× 126 0.7× 75 0.7× 31 1.3k
Antje Krenz Germany 9 515 1.0× 281 0.6× 170 0.7× 211 1.1× 140 1.3× 9 1.2k
Jakob Körbelin Germany 18 564 1.1× 254 0.5× 144 0.6× 140 0.7× 95 0.9× 43 1.2k
Tânia Cristina Leite de Sampaio e Spohr Brazil 18 814 1.6× 310 0.7× 133 0.5× 94 0.5× 138 1.3× 27 1.6k
Allen S. Liu United States 7 301 0.6× 326 0.7× 517 2.0× 167 0.9× 257 2.5× 9 1.5k
Kun Jin United States 12 815 1.6× 175 0.4× 315 1.2× 103 0.5× 410 3.9× 19 1.5k
Azeb Tadesse Argaw United States 14 724 1.5× 1.1k 2.3× 245 1.0× 203 1.1× 247 2.4× 16 2.2k

Countries citing papers authored by James Keaney

Since Specialization
Citations

This map shows the geographic impact of James Keaney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Keaney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Keaney more than expected).

Fields of papers citing papers by James Keaney

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Keaney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Keaney. The network helps show where James Keaney may publish in the future.

Co-authorship network of co-authors of James Keaney

This figure shows the co-authorship network connecting the top 25 collaborators of James Keaney. A scholar is included among the top collaborators of James Keaney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Keaney. James Keaney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Mendel, Marta, Paul Westwood, Claudia Bonardi, et al.. (2025). SARM1 base-exchange inhibitors induce SARM1 activation and neurodegeneration at low doses. 2(1). 2 indexed citations
2.
Lange, Simona, Martin Ebeling, Will Macnair, et al.. (2024). Fenebrutinib, a Bruton’s tyrosine kinase inhibitor, blocks distinct human microglial signaling pathways. Journal of Neuroinflammation. 21(1). 276–276. 5 indexed citations
3.
Limone, Francesco, Alexander Benavides Couto, Jinyuan Wang, et al.. (2024). Myeloid and lymphoid expression of C9orf72 regulates IL-17A signaling in mice. Science Translational Medicine. 16(732). eadg7895–eadg7895. 7 indexed citations
4.
Keaney, James, et al.. (2023). Divergent functional outcomes of NLRP3 blockade downstream of multi-inflammasome activation: therapeutic implications for ALS. Frontiers in Immunology. 14. 1190219–1190219. 6 indexed citations
5.
Gillet, Gaëlle, et al.. (2023). Innate immune activation and aberrant function in the R6/2 mouse model and Huntington’s disease iPSC-derived microglia. Frontiers in Molecular Neuroscience. 16. 1191324–1191324. 6 indexed citations
6.
Burberry, Aaron, Michael F. Wells, Francesco Limone, et al.. (2020). C9orf72 suppresses systemic and neural inflammation induced by gut bacteria. Nature. 582(7810). 89–94. 189 indexed citations
7.
Keaney, James, et al.. (2019). Inhibition of Bruton’s Tyrosine Kinase Modulates Microglial Phagocytosis: Therapeutic Implications for Alzheimer’s Disease. Journal of Neuroimmune Pharmacology. 14(3). 448–461. 68 indexed citations
8.
Keaney, James, et al.. (2019). Age-related changes in eye morphology and aqueous humor dynamics in DBA/2J mice using contrast-enhanced ocular MRI. Magnetic Resonance Imaging. 59. 10–16. 10 indexed citations
9.
Doherty, Colin P., Eoin O’Keeffe, James Keaney, et al.. (2018). Neuropolypathology as a result of severe traumatic brain injury?. Clinical Neuropathology. 38(1). 14–22. 1 indexed citations
10.
Doherty, Colin P., Eugene Wallace, James Keaney, et al.. (2016). Blood–Brain Barrier Dysfunction as a Hallmark Pathology in Chronic Traumatic Encephalopathy. Journal of Neuropathology & Experimental Neurology. 75(7). 656–662. 89 indexed citations
11.
Keaney, James, Dominic M. Walsh, Tiernan T. O’Malley, et al.. (2015). Autoregulated paracellular clearance of amyloid-β across the blood-brain barrier. Science Advances. 1(8). e1500472–e1500472. 116 indexed citations
12.
Keaney, James & Matthew Campbell. (2015). The dynamic blood–brain barrier. FEBS Journal. 282(21). 4067–4079. 468 indexed citations breakdown →
13.
Doyle, Sarah, Ema Ozaki, Kiva Brennan, et al.. (2014). IL-18 Attenuates Experimental Choroidal Neovascularization as a Potential Therapy for Wet Age-Related Macular Degeneration. Science Translational Medicine. 6(230). 230ra44–230ra44. 84 indexed citations
14.
Campbell, Matthew, Finnian Hanrahan, Oliviero L. Gobbo, et al.. (2012). Targeted suppression of claudin-5 decreases cerebral oedema and improves cognitive outcome following traumatic brain injury. Nature Communications. 3(1). 849–849. 91 indexed citations
15.
Tam, Lawrence C. S., Anna‐Sophia Kiang, Matthew Campbell, et al.. (2011). Protein Misfolding and Potential Therapeutic Treatments in Inherited Retinopathies. Advances in experimental medicine and biology. 723. 567–572. 1 indexed citations
16.
Keaney, James, Matthew Campbell, & Peter Humphries. (2011). From RNA Interference Technology to Effective Therapy: How Far have We Come and How Far to go?. Therapeutic Delivery. 2(11). 1395–1406. 8 indexed citations
17.
Tam, Lawrence C. S., Anna‐Sophia Kiang, Matthew Campbell, et al.. (2010). Prevention of autosomal dominant retinitis pigmentosa by systemic drug therapy targeting heat shock protein 90 (Hsp90). Human Molecular Genetics. 19(22). 4421–4436. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026